Major depression is a serious and debilitating disease for which current pharmacotherapy is inadequate in terms of limited efficacy, a long delay to onset of action and induction of side effects. All ...

A New Drug Class paper published Online First by The Lancet looks at the use of melatonin and its analogues—traditionally used to modify the body's internal clock (circadian system)—in the treatment ...

GlyphAgo is an oral prodrug of agomelatine, a medicine with established clinical efficacy in four out of four previous third-party randomized, placebo-controlled studies in generalized anxiety ...